SSA
TNYA icon

Schonfeld Strategic Advisors’s Tenaya Therapeutics TNYA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.3K Buy
+16,327
New +$12K ﹤0.01% 2085
2025
Q4 		– Sell
-465,957
Closed -$755K – 2585
2025
Q3 		$755K Buy
+465,957
New +$469K ﹤0.01% 1510
2024
Q4 		– Sell
-917,370
Closed -$1.77M – 2387
2024
Q3 		$1.77M Buy
917,370
+559,870
+157% +$1.58M 0.01% 935
2024
Q2 		$1.11M Buy
357,500
+167,500
+88% +$692K 0.01% 1165
2024
Q1 		$994K Buy
+190,000
New +$909K 0.01% 1234
2023
Q1 		– Sell
-11,100
Closed -$22.3K – 2651
2022
Q4 		$22.3K Sell
11,100
-7,000
-39% -$17.1K ﹤0.01% 2319
2022
Q3 		$52K Buy
+18,100
New +$84.5K ﹤0.01% 2639

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Schonfeld Strategic Advisors's TNYA Position: Q1 2026 in Review

Schonfeld Strategic Advisors opened a new position in Tenaya Therapeutics (TNYA) in Q1 2026: 16,327 shares worth $11.3K. The stake represents ﹤0.01% of the portfolio and ranks #2085 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in TNYA as recently as Q3 2025.

Schonfeld Strategic Advisors first reported a position in TNYA in Q3 2022 and has held it in 7 quarters since. The position peaked at $1.77M in Q3 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Schonfeld Strategic Advisors held 16,327 shares of Tenaya Therapeutics worth $11.3K as of Q1 2026.
  • Tenaya Therapeutics was a new Schonfeld Strategic Advisors position in Q1 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #2085 holding.
  • Schonfeld Strategic Advisors first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 7 quarters since.
  • Schonfeld Strategic Advisors's Tenaya Therapeutics position peaked at $1.77M in Q3 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.